NutriSystem Inc. (Nasdaq:NTRI) announced the first new success story contest winners of the New Year. The announcement comes after the Company conducted a national search, receiving hundreds of amazing online entries and then selecting the ten inspirational grand prize winners. Each winner receives a $5,000 grand prize and a chance to star in an upcoming Nutrisystem advertising campaign. The announcement follows the launch of the "New You Revolution/Hooray You," a national advertising and marketing initiative by Nutrisystem to celebrate and honor the everyday people who have achieved their weight loss goals on Nutrisystem. As part of the initiative, Nutrisystem launched a national advertising campaign featuring raw, unedited flip cam videos of members telling their weight loss success stories in their own words.
Nutrisystem, Inc. provides weight management products and services primarily in the United States and Canada. The companys weight management program principally comprises a pre-packaged food program, online tools, and counseling.
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc.'s management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.
In addition, PWRM is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by PWRM several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for PWRM's depressed stock price and have distracted the company from its mission, PWRM plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, PWRM will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. PWRM intends to appeal this decision.
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers.
With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents.
Power3 is also adding additional layers of research and license agreements, patent filings, and trade secrets, as its technology and product portfolio develops.
PWRM continues to discover new ways to test for Alzheimers, Parkinsons, and Breast Cancer!
To learn more about PWRM visit: http://www.Power3Medical.com
ViroPharma Inc. (Nasdaq:VPHM) announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the 29th Annual J.P. Morgan Healthcare Conference at 6:00 P.M. ET (3:00 P.M. PT) on Wednesday, January 12, 2011. The conference is being held at the Westin St. Francis Hotel in San Francisco. ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days following the conferences.
ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees.
Douglas Lake Minerals Inc. (OTC:DLKM)
DLKM recently released the results of the recent exploration program conducted on PLR PLR4973/2008, subsequently subdivided into four PL's (PL6742/2010, PL6743/2010, PL6744/2010 and PL6779/2010), based on the outcomes of the first phase of the continuous exploration program conducted since 2008. This exploration phase included a fixed-wing aircraft flown aeromagnetic and radiometric survey at a line spacing of 200m and a height of 80m, subsequent interpretation of data and ground follow-up. The survey and interpretation was conducted according to internationally accepted standards by the Council for Geoscience, South Africa.
Interpretation of aeromagnetic data was successful in delineating prominent structural features including NW-SE shear zones of which five in DLKM's property area, with a total length of 143km, are given first order priority. These shear zones and their distances within DLKM's properties are: 1 - Southwestern shear zone (31km); 2 - Kimamba shear zone (41km); 3 - Kilima Mzinga - Kwandege main shear zone (28km); 4 - Mligazi shear zone (15km); and 5 - Magambazi - Mjembe (28km) shear zone. DLKM has identified three further key elements in the delineation of gold mineralization which includes the prominence of NE-SW lineaments (seven in total), the role of SW to NE thrust planes and the use of radioelements to outline potential target areas. Three major SW to NE thrusts planes were also identified: a main thrust zone of 46km; and two additional thrusts zones of 5km and 3km each. In addition to the key elements sheath folding, open folds (2km to 10km scale) and boudinage provide additional targets with a second order priority.
The position of regional gold mining activities, as well as known gold mineralization occurrences, were utilized to test the Company's developed model for locating gold mineralization and this approach proved to be successful. Following from this DLKM considers the Kilima Mzinga - Kwandege shear zone, with a distance of 28km in PL6742, PL6779 and PL6744 as one of their primary targets, substantiated by the artisanal mining activities along the northwestern and southwestern outcrop area of the shear. In addition to the shear component along the Kilima Mzinga - Kwandege shear zone, a considerable SW to NE thrust component acted along a 25km long stretch of the shear within DLKM's property adding to the gold mineralization potential of this zone based on the current model.
The technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in NI 43-101 and has been reviewed by Reyno Scheepers, Ph.D., Pr.Sci.Nat, Director of Exploration and a director of DLKM, a QP under NI 43-101.
Douglas Lake Minerals Inc. offers gold mining and exploration services. DLKM is based in Surrey, Canada.
To learn more about DLKM visit: http://www.douglaslakeminerals.com
First Niagara Financial Group Inc. (Nasdaq:FNFG) announced that it will release 2010 fourth quarter earnings before the market opens on Thursday, January 27, 2011. A conference call will follow at 11:00 a.m. Eastern Time, in which management will discuss the Company's financial results and business strategy, followed by a question-and-answer session. First Niagara Financial Group, Inc., through its wholly owned subsidiary, First Niagara Bank, N.A., has $21 billion in assets, 257 branches and $13 billion in deposits. First Niagara Bank is a multi-state community-oriented bank with about 3,800 employees providing financial services to individuals.
First Niagara Financial Group, Inc. operates as the holding company for First Niagara Bank that provides retail and commercial banking, and other financial services to individuals, families, and businesses.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.